Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017
November 02 2017 - 4:47PM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX:
AEZS) (the “Company”) will announce its third quarter 2017
financial and operating results after market close on Wednesday,
November 8, 2017. The Company will host a conference call to
discuss these results on Thursday, November 9, 2017 at 8:30 a.m.
Eastern Time.
Participants may access the conference call using the following
numbers:
- Toll-Free: 877-407-8029, Confirmation
#13672701
- Toll: 201-689-8029, Confirmation
#13672701
A replay of the conference call will also be available on the
Company’s website for a period of 30 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel pharmaceutical
therapies. We are engaged in drug development activities and in the
promotion of products for others. We recently resubmitted an NDA to
the FDA seeking approval of MacrilenTM, an internally developed
compound. The focus of our business development efforts is the
acquisition of licenses to products that are relevant to our
therapeutic areas of focus. We also intend to license out certain
commercial rights of internally developed products to licensees in
non-U.S. territories where such out-licensing would enable us to
ensure development, registration and launch of our product
candidates. Our goal is to become a growth-oriented specialty
biopharmaceutical company by pursuing successful development and
commercialization of our product portfolio, achieving successful
commercial presence and growth, while consistently delivering value
to our shareholders, employees and the medical providers and
patients who will benefit from our products. For more information,
visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171102006857/en/
Aeterna Zentaris Inc.Michael V. WardChief Executive
OfficerIR@aezsinc.com843-900-3223orReilly ConnectSusan
ReillyPresidentsusan.reilly@reillyconnect.com312-600-6783
Aeterna Zentaris (TSX:AEZS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aeterna Zentaris (TSX:AEZS)
Historical Stock Chart
From Apr 2023 to Apr 2024